Abstract Colorectal cancer (CRC) remains a significant global health challenge, with oxidative stress and chronic inflammation being key drivers of its pathogenesis
In such cases, a clinician might consider adding a DPP-4 inhibitor like sitagliptin or linagliptin to squeeze out additional 0.51.0% HbA1c reduction
La formulation orale a ncessit l'ajout d'un agent facilitateur d'absorption (SNAC) pour permettre au semaglutide de franchir la barrire gastrique sans tre dgrad
Less water = stronger concentration
Within the emerging geroscience paradigm 2 , pharmacologic agents originally developed for metabolic indications, such as GLP-1 receptor agonists 3,4,5,6 , have garnered attention due to their potential dual roles in metabolic regulation and aging biology 7
In this randomized trial, once-weekly exenatide (2 mg) led to a weight loss of more than 4 kg after 52 weeks